ZHONG Wen-zhao, CHEN Ying. CrizotinibNeoadjuvant Therapy for ⅢA/N2 Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 186-192. DOI: 10.12019/j.issn.1671-5144.2016.03.015
|
Citation:
|
ZHONG Wen-zhao, CHEN Ying. CrizotinibNeoadjuvant Therapy for ⅢA/N2 Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 186-192. DOI: 10.12019/j.issn.1671-5144.2016.03.015
|
ZHONG Wen-zhao, CHEN Ying. CrizotinibNeoadjuvant Therapy for ⅢA/N2 Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 186-192. DOI: 10.12019/j.issn.1671-5144.2016.03.015
|
Citation:
|
ZHONG Wen-zhao, CHEN Ying. CrizotinibNeoadjuvant Therapy for ⅢA/N2 Lung Cancer[J]. Journal of Evidence-Based Medicine, 2016, 16(3): 186-192. DOI: 10.12019/j.issn.1671-5144.2016.03.015
|
DownLoad: